Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Mural Oncology plc shares valued at $14,491 were purchased by Loew Caroline on Mar 04 ’25. At $3.36 per share, Loew Caroline acquired 4,313 shares.
Also, Keson-Brookes Maiken sold 1,469 shares, netting a total of over 5,068 in proceeds. Following the sale of shares at $3.45 each, the insider now holds 73,564 shares.
Before that, Keson-Brookes Maiken had sold 1,262 shares from its account. In a trade valued at $4,240, the insider traded Mural Oncology plc shares for $3.36 each. Upon closing the transaction, the insider’s holdings decreased to 1,262 shares, worth approximately $0.19 million.
As published in a research note from Raymond James on March 25, 2025, Mural Oncology plc [MURA] has been rated down from a Strong buy to an Outperform and the price target has been revised to $18. Analysts at Morgan Stanley downgraded the stock from ‘”an Overweight”‘ to ‘”an Equal-weight”‘ outlook in a report released in late March. As of June 28, 2024, Rodman & Renshaw has initiated its “Buy” rating for MURA. Earlier on April 04, 2024, Morgan Stanley initiated its rating. Their recommendation was “an Overweight” for MURA stock.
Analyzing MURA Stock Performance
On last trading session,, Mural Oncology plc [NASDAQ: MURA] rose 1.23% to $2.47. The stock’s lowest price that day was $2.44, but it reached a high of $2.48 in the same session. During the last five days, there has been a drop of approximately -3.52%. Over the course of the year, Mural Oncology plc shares have dropped approximately -23.29%. Shares of the company reached a 52-week high of $4.74 on 02/07/25 and a 52-week low of $0.95 on 04/09/25.
Support And Resistance Levels for Mural Oncology plc (MURA)
According to the 24-hour chart, there is a support level at 2.44, which, if violated, would cause prices to drop to 2.42. In the upper region, resistance lies at 2.49. The next price resistance is at 2.52. RSI (Relative Strength Index) is 43.03 on the 14-day chart, showing neutral technical sentiment.
Is Mural Oncology plc subject to short interest?
Stocks of Mural Oncology plc saw a sharp steep in short interest on 2025-05-30 dropping by -0.62 million shares to 0.34 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 0.97 million shares. A decline of -182.52% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 1.54 of the overall float, the days-to-cover ratio (short ratio) decline to 1.54.
